COMMUNIQUÉS West-GlobeNewswire

Combined General Meeting of June 30, 2026 - Availability of the Preparatory Documents
09/06/2026
Daix (France), New York City (New York, United States), June 9,2026 – Inventiva (Euronext Paris and NASDAQ: IVA ) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]
Assemblée Générale Mixte du 30 juin 2026 - Modalités de mise à disposition des documents préparatoires
09/06/2026
Daix (France), New York City (New York, United States), le 9 juin 2026 – Inventiva (Euronext Paris et Nasdaq : IVA ) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement d’une [...]
Tevogen Announces Formation of a Healthcare Services Initiative
09/06/2026
William Keane Appointed Interim Head of Initiative, Evaluating Potential Management Services Organization and Contract Research Organization Acquisitions WARREN, N.J., June 09, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen [...]
Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN
09/06/2026
CHICAGO, June 09, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that its wholly-owned [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
09/06/2026
ZUG, Switzerland, June 09, 2026 (GLOBE NEWSWIRE) -- The attached notification relates to the purchase of ordinary shares by a member of the Company’s Executive Committee and Board of Directors. Attachment notification- [...]
Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference
09/06/2026
MOUNTAIN VIEW, Calif., June 09, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for [...]
AB Science is invited to present at the 2026 ENCALS annual meeting the survival data from masitinib clinical program in ALS
09/06/2026
PRESS RELEASE AB SCIENCE IS INVITED TO PRESENT AT THE 2026 ENCALS ANNUAL MEETING THE SURVIVAL DATA FROM MASITINIB CLINICAL PROGRAM IN AMYOTROPHIC LATERAL SCLEROSIS Masitinib treatment has been linked to a 5-year [...]
Applied Biologics Receives FDA Clearance to Advance BIOxHEAL Into Phase 3 Clinical Development for Diabetic Foot Ulcers
09/06/2026
SCOTTSDALE, Ariz., June 09, 2026 (GLOBE NEWSWIRE) -- Applied Biologics , a biopharmaceutical company developing novel biologic therapies for chronic wounds, tissue repair, and degenerative disease, today announced that [...]
AB Science présentera, lors du congrès annuel 2026 de l'ENCALS, les données de survie issues du programme clinique du masitinib dans la SLA
09/06/2026
COMMUNIQUÉ DE PRESSE AB SCIENCE PRÉSENTERA, LORS DU CONGRÈS ANNUEL 2026 DE L'ENCALS, LES DONNÉES DE SURVIE ISSUE DU PROGRAMME CLINIQUE DU MASITINIB DANS LA SCLÉROSE LATÉRALE AMYOTROPHIQUE Le traitement avec le masitinib [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 mai 2026
09/06/2026
Nombre total de droits de vote et d’actions composant le capital social au 31 mai 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of May 31, 2026
09/06/2026
Disclosure of Share Capital and Voting Rights Outstanding as of May 31, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Alembic Therapeutics, LLC Announces Acquisition of NUVESSA® (metronidazole vaginal gel 1.3%) from Exeltis USA, Inc.
09/06/2026
BEDMINSTER, N.J., June 09, 2026 (GLOBE NEWSWIRE) -- Alembic Therapeutics, LLC announces the acquisition of NUVESSA ® (metronidazole vaginal gel 1.3%), an FDA-approved prescription medication indicated for the treatment [...]
FDA Expands Sunscreen Options for the First Time in 20 Years
09/06/2026
Silver Spring, Md., June 09, 2026 (GLOBE NEWSWIRE) -- Today, the U.S. Food and Drug Administration added bemotrizinol to the list of permitted sunscreen active ingredients, marking a significant milestone in the agency' [...]
Ally Medical ER Is Coming to Magnolia
09/06/2026
A new 24/7 emergency room is coming to Montgomery County's fastest-growing community, designed with local families in mind MAGNOLIA, Texas, June 09, 2026 (GLOBE NEWSWIRE) -- Ally Medical Emergency Room has announced [...]
Koi Peptides Survey Finds 75% of Lab Researchers Cite Sourcing Quality as Top Concern
09/06/2026
Cheyenne, WY, June 09, 2026 (GLOBE NEWSWIRE) -- A new Koi Peptides survey of 412 laboratory researchers found that 75% rank sourcing quality among their top concerns when buying research peptides, placing it above price [...]
AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market under NYSE American Rules
09/06/2026
OCALA, Fla., June 09, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc . (NYSE American: AIM) (“AIM” or the “Company”), today announced that it has entered into definitive agreements for a registered direct offering and [...]
Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (EMA)
09/06/2026
MIAMI, June 09, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, [...]
Legend Senior Living Earns Great Place to Work® Certification™ for Eighth Consecutive Year
09/06/2026
WICHITA, Kan., June 09, 2026 (GLOBE NEWSWIRE) -- Legend Senior Living ® has earned Great Place to Work ® Certification ™ for the eighth consecutive year, a distinction based entirely on feedback from associates through [...]
AMN Healthcare Acquires Jaide Health to Expand Language Access Across the Patient Journey Through AI Technology
09/06/2026
Acquisition strengthens end-to-end support for Limited English Proficiency (LEP) patients by pairing high-quality AI assistance with AMN’s trusted human interpreter services DALLAS, June 09, 2026 (GLOBE NEWSWIRE) -- AMN [...]

Pages